David Singer

747 total citations
52 papers, 452 citations indexed

About

David Singer is a scholar working on Epidemiology, Dermatology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, David Singer has authored 52 papers receiving a total of 452 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Epidemiology, 9 papers in Dermatology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in David Singer's work include Herpesvirus Infections and Treatments (13 papers), Respiratory viral infections research (9 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (7 papers). David Singer is often cited by papers focused on Herpesvirus Infections and Treatments (13 papers), Respiratory viral infections research (9 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (7 papers). David Singer collaborates with scholars based in United States, Canada and Belgium. David Singer's co-authors include Vittorio Maio, Marco Lombardi, Shaun Wen Huey Lee, Wendell C. Valdecantos, Wendy C. Cox, Jacqueline E. McLaughlin, Shahnaz Khan, Margaret Reed Lewis, Sara Poston and Raunak Parikh and has published in prestigious journals such as Circulation, Physical review. B, Condensed matter and Annals of the Rheumatic Diseases.

In The Last Decade

David Singer

46 papers receiving 444 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Singer United States 12 138 81 68 62 59 52 452
Nina M. de Gruijter United Kingdom 6 91 0.7× 6 0.1× 87 1.3× 56 0.9× 26 0.4× 9 952
Kevin Shi United States 9 95 0.7× 131 1.6× 86 1.3× 38 0.6× 4 0.1× 24 591
Marcel Ballin Sweden 13 64 0.5× 19 0.2× 47 0.7× 84 1.4× 6 0.1× 31 754
Jessica Risser United States 8 115 0.8× 190 2.3× 4 0.1× 34 0.5× 52 0.9× 8 776
Elizabeth Palmer United States 10 96 0.7× 9 0.1× 19 0.3× 84 1.4× 20 0.3× 27 467
Allan Pollack Australia 10 111 0.8× 21 0.3× 7 0.1× 72 1.2× 14 0.2× 26 346
Katherine Brown Australia 11 65 0.5× 9 0.1× 111 1.6× 63 1.0× 48 0.8× 27 626
Michelle Floris-Moore United States 23 346 2.5× 15 0.2× 39 0.6× 128 2.1× 3 0.1× 51 1.5k
Nhu D. Le Canada 13 72 0.5× 16 0.2× 18 0.3× 81 1.3× 7 0.1× 27 586
Puja Van Epps United States 10 171 1.2× 73 0.9× 33 0.5× 16 0.3× 4 0.1× 30 360

Countries citing papers authored by David Singer

Since Specialization
Citations

This map shows the geographic impact of David Singer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Singer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Singer more than expected).

Fields of papers citing papers by David Singer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Singer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Singer. The network helps show where David Singer may publish in the future.

Co-authorship network of co-authors of David Singer

This figure shows the co-authorship network connecting the top 25 collaborators of David Singer. A scholar is included among the top collaborators of David Singer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Singer. David Singer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Singer, David, Yan Wang, Aozhou Wu, et al.. (2025). RSV Testing Patterns and Characteristics Associated with RSV Testing Among Adults Aged 50 Years or Older in the United States. Infectious Diseases and Therapy. 14(10). 2321–2340.
2.
Singer, David, Yan Wang, Aozhou Wu, et al.. (2025). P-686. Risk of COPD Exacerbations, Asthma Exacerbations, and Hospitalizations for Heart Failure after RSV Hospitalization Among US Adults Aged at Least 50 Years. Open Forum Infectious Diseases. 12(Supplement_1). 2 indexed citations
3.
4.
Singer, David, Philippe Thompson‐Leduc, Wendy Y. Cheng, et al.. (2024). Burden of Herpes Zoster Among Patients with Psoriatic Arthritis in the United States. PubMed. Volume 14. 63–78.
5.
La, Elizabeth M., James E. Graham, David Singer, et al.. (2024). Cost-effectiveness of the adjuvanted RSVPreF3 vaccine among adults aged ≥60 years in the United States. Human Vaccines & Immunotherapeutics. 20(1). 2432745–2432745. 4 indexed citations
6.
Singer, David, et al.. (2024). Knowledge, Attitudes, and Practices Regarding Herpes Zoster Vaccination Among Specialists. Population Health Management. 27(4). 231–240. 2 indexed citations
7.
Parikh, Raunak, et al.. (2023). Effectiveness and safety of recombinant zoster vaccine: A review of real-world evidence. Human Vaccines & Immunotherapeutics. 19(3). 20 indexed citations
8.
9.
Singer, David, Philippe Thompson‐Leduc, Sara Poston, et al.. (2023). Economic and Clinical Burden of Herpes Zoster Among Patients With Inflammatory Bowel Disease in the United States. Crohn s & Colitis 360. 5(3). otad033–otad033. 3 indexed citations
10.
Singer, David, Philippe Thompson‐Leduc, Sara Poston, et al.. (2023). Clinical and Economic Burden of Herpes Zoster in Patients with Rheumatoid Arthritis: A Retrospective Cohort Study Using Administrative Claims. Rheumatology and Therapy. 10(4). 933–950. 7 indexed citations
11.
Singer, David, Philippe Thompson‐Leduc, Sara Poston, et al.. (2023). Incidence of Herpes Zoster in Patients With Rheumatoid Arthritis in the United States: A Retrospective Cohort Study. The Journal of Rheumatology. 50(7). 873–880. 11 indexed citations
12.
Singer, David, Philippe Thompson‐Leduc, Wendy Y. Cheng, et al.. (2023). Burden of Herpes Zoster Among Patients with Psoriasis in the United States. Dermatology and Therapy. 13(11). 2649–2668. 5 indexed citations
13.
Curran, Desmond, et al.. (2022). Modeled impact of the COVID-19 pandemic and associated reduction in adult vaccinations on herpes zoster in the United States. Human Vaccines & Immunotherapeutics. 18(1). 2027196–2027196. 6 indexed citations
14.
Singer, David, Philippe Thompson‐Leduc, Wendy Y. Cheng, et al.. (2022). Incidence and risk of herpes zoster in patients with ulcerative colitis and Crohn’s disease in the USA. Gastroenterology report. 11. goad016–goad016. 6 indexed citations
15.
Singer, David, et al.. (2022). Care patterns of patients with chronic fibrosing interstitial lung disease (ILD) with a progressive phenotype. BMC Pulmonary Medicine. 22(1). 153–153. 1 indexed citations
16.
Singer, David, et al.. (2021). Economic burden of generalized pustular psoriasis and palmoplantar pustulosis in the United States. Current Medical Research and Opinion. 37(5). 735–742. 23 indexed citations
17.
Pilon, Dominic, et al.. (2020). Use of home health and other healthcare delivery pathways among privately insured patients with and without treatment-resistant depression. Current Medical Research and Opinion. 36(5). 865–874. 1 indexed citations
18.
Olson, Amy L., N Hartmann, Padmaja Patnaik, et al.. (2020). PRS25 HEALTHCARE RESOURCE UTILIZATION AND RELATED COSTS IN PROGRESSIVE FIBROSING INTERSTITIAL LUNG DISEASES (ILDS). Value in Health. 23. S353–S353. 2 indexed citations
19.
Alcusky, Matthew, David Singer, Scott W. Keith, et al.. (2019). Evaluation of Care Processes and Health Care Utilization in Newly Implemented Medical Homes in Italy: A Population-Based Cross-sectional Study. American Journal of Medical Quality. 35(3). 265–273. 3 indexed citations
20.
Cox, Wendy C., et al.. (2015). Development and Assessment of the Multiple Mini-Interview in a School of Pharmacy Admissions Model. American Journal of Pharmaceutical Education. 79(4). 53–53. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nina M. de Gruijter Breakdown of academic impact, for papers by Kevin Shi Breakdown of academic impact, for papers by Marcel Ballin Breakdown of academic impact, for papers by Jessica Risser Breakdown of academic impact, for papers by Elizabeth Palmer Breakdown of academic impact, for papers by Allan Pollack Breakdown of academic impact, for papers by Katherine Brown Breakdown of academic impact, for papers by Michelle Floris-Moore Breakdown of academic impact, for papers by Nhu D. Le Breakdown of academic impact, for papers by Puja Van Epps
Rankless by CCL
2026